I. Borza and A. Babes, “FECAL CALPROTECTIN DOSAGE VALUE AS A DIAGNOSTIC AND POSTOPERATIVE MARKER IN DIABETIC PATIENTS WITH COLORECTAL CANCER”, RJDNMD, vol. 22, no. 1, pp. 11-18, Mar. 2015.